AzTrials
AzTrials

Brain DevelopmentNCT05040542

The Brain Mechanism of Social Emotion and Communication in Infants Aged 0 to 6 Years

An observational study of Brain Development and Behavior Disorders, Child, run by Children's Hospital of Fudan University at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study explores the relationship between brain development and infants' social emotion and communication ability, as well as the role of genetic factors and maternal exposure during pregnancy (e.g., environmental exposures and maternal inflammatory states). Read more about this study

Who is it for?
Ages Up to 6 yearsHealthy volunteers can take part
What is being tested?
maternal exposure during pregnancy
How many people
3,001 participants
Where
1 siteChina
Study dates
1 Aug 2021to 31 Aug 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 6 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Infants aged 0-6 years are mainly recruited from the society and Xiamen Children\'s Hospital.

Who may be able to join

  • Age 0-6 years
  • Born at 34-42 weeks of gestation
  • Birth weight\>1500g
  • Normal brain function assessment
  • Parents can understand and sign informed consent

Who cannot join

  • The mother had severe complications during pregnancy and delivery
  • History of asphyxiation at birth
  • Have congenital structural malformation
  • Have congenital metabolic disease
  • Have major or genetic diseases that affect growth, development or cognition
  • Have contraindications to MRI scanning

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Wenhao Zhou, Prof contact

(+86) 021-64931168

zwhchfu@126.com

Deyi Zhuang, Dean contact

15959279526

zhuangdy526@163.com

China1 site, 1 recruiting
  • Xiamen Children's Hospital

    Xiamen, Fujian, 361000

    Deyi Zhuang, Dean, 15959279526, zhuangdy526@163.com

    Xianghui Huang, Director, 13799250830, xmhxh2013@163.com

    Recruiting

Other trials in China

About this study

Official title: A Cohort Study on the Brain Mechanism of Social Emotion and Communication in Infants Aged 0 to 6 Years

This study explores the relationship between brain development and infants' social emotion and communication ability, as well as the role of genetic factors and maternal exposure during pregnancy (e.g., environmental exposures and maternal inflammatory states). To provide a theoretical basis for precise intervention of infants' social emotion and communication problems and the overall improvement of brain development.

Read the detailed description

This study uses functional magnetic resonance imaging (fMRI) is a ultra-fast imaging technology to reflect the changes in brain function when the brain is stimulated or pathologically affected. There are 4 working imaging techniques for fMRI, including blood-oxygen-level dependent fMRI, perfusion weighted imaging (PWI), perfusion weighted imaging (PWI) and MRI spectroscopy. fMRI combine with cloud computing to analyze brain structure, brain function, brain connection, brain development trajectory, multi-modal brain imaging artificial Intelligent calculation, and draw dynamic connection maps of brain development in children aged 0-6 years. In addition, using the Chinese Urban Children's Emotion and Social Assessment Scale (CITSEA) to evaluate children's social and emotional behavior and Gesell Developmental Scale (GDS) to assess the neurological integrity and functional maturity of children, and explore their relationship with brain imaging. The researchers will collect blood samples from the enrollees for whole exome sequencing as well as exposome testing to look for genes related to brain intellectual development and biomarkers related to brain development and to explore their relationship with brain imaging. In addition, the researchers will collect basic information about the family and the mother's health during pregnancy through baseline questionnaires and clinical history data, which will be used to explore pregnancy risk factors for children's brain development and the role of these factors in brain development and the baby's social-emotional and communication skills.

This study explores the relationship between brain development and infants' social emotion and communication ability, as well as the role of genetic factors and maternal exposure during pregnancy (e.g., environmental exposures and maternal inflammatory states). To provide a theoretical basis for precise intervention of infants' social emotion and communication problems and the overall improvement of brain development.

Being tested
maternal exposure during pregnancy
Keywords
Preterm, Newborn, Neonates, Infants, Children, Brain, Development
Medical subject headings
Child Behavior Disorders, Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • maternal exposure during pregnancyOther

    maternal exposure during pregnancy (e.g., environmental exposures and maternal inflammatory states)

Study groups in NCT05040542
Study groupRoleWhat they receive
Infant CohortHealthy infants aged from 0-72 months.This is an observational trial so no intervention will be provided, with exception of study assessments, including fMRI.
Receives: Other: maternal exposure during pregnancy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Brain structure (cortical thickness) change of subjects

    Using T1 weighted and T2 weighted images to measure brain cortical thickness, analyzing the brain structural changes (differences of cortical thickness) over time.

    Measured: at baseline,and 6 months after baseline.

  2. Brain structural connectivity change of subjects

    Using diffusion-weighted images to measure the structural connectivity matrix (based on fiber tracking) of brain, analyzing the brain structural connectivity changes (differences in fibers number) over time.

    Measured: at baseline,and 6 months after baseline.

  3. Brain functional connectivity change of subjects

    Using resting state functional MRI (blood-oxygen-level dependent) to measure the functional connectivity matrix, analyzing the brain functional connectivity (differences in connectivity strength) changes over time.

    Measured: at baseline,and 6 months after baseline.

  4. Cerebral blood flow change of subjects

    Using arterial spin labeling (ASL) to measure relative cerebral blood flow (rCBF) can produce quantitative cerebral perfusion images, analyzing the change (differences in rCBF) of brain perfusion over time.

    Measured: at baseline,and 6 months after baseline.

  5. EEG examination change of subjects

    EEG data were collected at each follow-up visit. Electroencephalogram (EEG), especially the event-related potential (ERP) technique, can non-invasively explore the cognitive processes of infant speech recognition, language comprehension, phonological awareness, recognition memory, and facial emotion recognition. The study will collect EEG data from children in resting states, including the power spectral density of different frequency bands (e.g., delta, theta, alpha, beta, gamma), ERP waveform, amplitude, and latency during specific cognitive or sensory tasks, and EEG network connectivity in resting and task states. Through an experimental paradigm designed specifically for different age groups, the influential factors of language and social-emotional development in 0-3 years old infants were explored.

    Measured: at baseline, and 6 months after baseline.

  6. Social and emotional behavior change of subjects (CITSEA score)

    Using Chinese Version of Urban Infant-Toddler Social and Emotional Assessment (CITSEA) to evaluate children's social and emotional behavior, including four broad domains: 1) externalizing problems; 2) internalizing problems; 3) dysregulation problems; 4) competencies. The problem behavior domain T score >63 is assessed as suspicious positive, indicating possible social-emotional behavior problems; the competencies domain T score <37 is assessed as suspicious positive, indicating there may be a delay in the development of social-emotional ability, analyzing the CITSEA score changes over time.

    Measured: at baseline,and 6 months after baseline.

  7. Brain development change of subjects (GDS score)

    Using Gesell Development Scale (GDS) to assess neurological integrity and functional maturity of children, including adaptive behavior, gross motor behavior, fine motor behavior, language behavior and personal social behavior. Mild intellectual disability: 55≤DQ≤75; moderate intellectual disability: 40≤DQ≤54; severe mental disability:25≤DQ≤39; extreme intellectual disability: DQ<25, analyzing the GDS score changes over time.

    Measured: at baseline,and 6 months after baseline.

  8. Developmental level prediction change of subjects (brain age, CITSEA and GDS score)

    Using a connectome-based predictive model (CPM) to predict the developmental levels of subjects. In the modal training procedure, extracted multimodal MRI measures (primary outcomes 1 to 4) are input features, and the age, CITSEA and GDS score are ground truths.

    Measured: at baseline,and 6 months after baseline.

  9. Child behavioral development change of subjects

    Griffiths Development Scales - Chinese Edition (GDSC) : Griffith scale in Chinese children aged 0 ~ 8 speakers of standardized rating scale, with Chinese standard. The scale is divided into two parts, 0-2 years old and 0-8 years old. The 0-2 years old part is composed of 5 fields: The 0-2 years old part is composed of 5 fields, such as "A action ", "B individual-social ", "C language ", "D hand-eye coordination "and "E performance", and the 0-8 years old part adds "F practical reasoning field "on this basis. When the development quotient DQ<70, development is delayed, and when DQ≥85, development is normal.

    Measured: at baseline,and 6 months after baseline.

  10. Child mental health change of subjects

    Ages and Stages Questionnaires: Social-Emotional, Second Edition (ASQ:SE-2) : This scale is used to assess a child's social-emotional development. In general, a higher score means a child needs more attention or is in a higher risk state for social-emotional development.

    Measured: at baseline, and 6 months after baseline.

  11. Intelligence quotient change of subjects

    Wechsler Intelligence Scale for Children - Fourth Edition (WISC-IV) : Use the Chinese version (revised by Professor Zhang Houcan) to assess children's intelligence level. Choose 10 core tests and 4 auxiliary tests from WISC-IV. Four scores, namely the Verbal Comprehension index (VCI), Perceptual Reasoning Index (PRI), Working memory Index (WMI), and processing speed Index (PSI), were calculated from the question bank, and the four composite scores were recombined to form the General Ability Index (GAI) and Cognitive Ability Index (CPI). The resulting total Intelligence quotient (FSIQ). A FSIQ score between 85 and 115 is considered normal intelligence; Between 70 and 84 are classified as borderline intelligence; Less than 70 is classified as low intelligence.

    Measured: at 3 years old, 4 years old, 5 years old, and 6 years old.

Secondary outcomes (2)
  1. Biomarker Screening

    At enrollment, 0.5 ml of blood was drawn from each parent and child for the exposome. High - throughput sequencing technology will be used to screen for biomarkers associated with brain development.

    Measured: one time blood draw at baseline.

  2. Relationship Assessment between Biomarkers and Development

    The relationship between the identified biomarkers and children's cognitive and emotional development will be assessed. This will provide a database for understanding the relationship between environment and development, and a scientific basis for future intervention strategies.

    Measured: at baseline.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Sep 2021
  2. Study start1 Aug 2021
  3. Primary completion31 Aug 2026 (estimated)
  4. Study completion31 Aug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
3,001 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05040542
Sponsor's protocol ID
CCBN_01
Status last verified
Nov 2024
First submitted
29 Jul 2021
Last updated
19 Nov 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Ball G, Pazderova L, Chew A, Tusor N, Merchant N, Arichi T, Allsop JM, Cowan FM, Edwards AD, Counsell SJ. Thalamocortical Connectivity Predicts Cognition in Children Born Preterm. Cereb Cortex. 2015 Nov;25(11):4310-8. doi: 10.1093/cercor/bhu331. Epub 2015 Jan 16.

    PubMed 25596587
  • Cao M, He Y, Dai Z, Liao X, Jeon T, Ouyang M, Chalak L, Bi Y, Rollins N, Dong Q, Huang H. Early Development of Functional Network Segregation Revealed by Connectomic Analysis of the Preterm Human Brain. Cereb Cortex. 2017 Mar 1;27(3):1949-1963. doi: 10.1093/cercor/bhw038.

    PubMed 26941380
  • Cao M, Huang H, He Y. Developmental Connectomics from Infancy through Early Childhood. Trends Neurosci. 2017 Aug;40(8):494-506. doi: 10.1016/j.tins.2017.06.003. Epub 2017 Jul 3.

    PubMed 28684174
  • Emerson RW, Adams C, Nishino T, Hazlett HC, Wolff JJ, Zwaigenbaum L, Constantino JN, Shen MD, Swanson MR, Elison JT, Kandala S, Estes AM, Botteron KN, Collins L, Dager SR, Evans AC, Gerig G, Gu H, McKinstry RC, Paterson S, Schultz RT, Styner M; IBIS Network; Schlaggar BL, Pruett JR Jr, Piven J. Functional neuroimaging of high-risk 6-month-old infants predicts a diagnosis of autism at 24 months of age. Sci Transl Med. 2017 Jun 7;9(393):eaag2882. doi: 10.1126/scitranslmed.aag2882.

    PubMed 28592562
  • Emerson RW, Gao W, Lin W. Longitudinal Study of the Emerging Functional Connectivity Asymmetry of Primary Language Regions during Infancy. J Neurosci. 2016 Oct 19;36(42):10883-10892. doi: 10.1523/JNEUROSCI.3980-15.2016.

    PubMed 27798142
  • Tavor I, Parker Jones O, Mars RB, Smith SM, Behrens TE, Jbabdi S. Task-free MRI predicts individual differences in brain activity during task performance. Science. 2016 Apr 8;352(6282):216-20. doi: 10.1126/science.aad8127. Epub 2016 Apr 7.

    PubMed 27124457
  • Zhang Y, Shi F, Wu G, Wang L, Yap PT, Shen D. Consistent Spatial-Temporal Longitudinal Atlas Construction for Developing Infant Brains. IEEE Trans Med Imaging. 2016 Dec;35(12):2568-2577. doi: 10.1109/TMI.2016.2587628. Epub 2016 Jul 7.

    PubMed 27392345
  • Zhang W, Li R, Deng H, Wang L, Lin W, Ji S, Shen D. Deep convolutional neural networks for multi-modality isointense infant brain image segmentation. Neuroimage. 2015 Mar;108:214-24. doi: 10.1016/j.neuroimage.2014.12.061. Epub 2015 Jan 3.

    PubMed 25562829
  • Huang X, Su C, Lin Y, Zhou T, Ye R, Li D, Liu M, Wu G, Li W, Xie N, Deng X, Zhu N, Lin S, Li Q, Yan K, Zhuang D. Cohort protocol: risk assessment of maternal inflammation and early brain development in infants and young children based on multi-source data modeling. Front Public Health. 2025 Jul 14;13:1530285. doi: 10.3389/fpubh.2025.1530285. eCollection 2025.

    PubMed 40726941
  • Xu X, Wang Z, Zhang W, Guo J, Wei W, Zhang M, Ding X, Liu X, Yang Q, Wang K, Zhu Y, Sun J, Song H, Shen Z, Chen L, Shi F, Wang Q, Li Y, Zhang H, Li D. Behavioral observation and assessment protocol for language and social-emotional development study in children aged 0-6: the Chinese baby connectome project. BMC Psychol. 2024 Oct 4;12(1):533. doi: 10.1186/s40359-024-02031-x.

    PubMed 39367488

Questions about this trial

What is this clinical trial studying?

An observational study of Brain Development and Behavior Disorders, Child, run by Children's Hospital of Fudan University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 19 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Wenhao Zhou, Prof ((+86) 021-64931168, zwhchfu@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Brain structure (cortical thickness) change of subjects (time frame: at baseline,and 6 months after baseline.). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05040542, which also lists 10 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in